Phase IV Low Intervention Clinical Trial to Study Biomarkers of "inflammageing" and Senescence in Pre-diabetic Patients Treated with Metformin: A Study nested within the project “NLRP3 Inflammasome at the Crossroad of Vascular Inflammageing: A Novel Target for Senomorphic Drugs”.
Pre-diabetes means your blood sugar levels are higher than normal, which can cause quiet, low-level inflammation inside your blood vessels over time. This inflammation can speed up how quickly your cells age, a process sometimes called 'inflammageing'. This Phase IV clinical trial is testing whether an established medicine called metformin (brand name Dianben, 850 mg) helps calm this inflammation and protects cells from ageing prematurely. Metformin is already widely used and trusted around the world to treat type 2 diabetes. Participants will take a daily metformin tablet and attend regular hospital or clinic check-ups over an 18-month period. During these visits, doctors will check your general health, measure your blood sugar and cholesterol, and take blood tests to look closely at signs of cell health and inflammation.
Auf einen Blick
Worum geht es in dieser Studie?
As we get older, our bodies naturally experience a gradual increase in low-grade inflammation. When someone has pre-diabetes, higher sugar levels in the blood can speed up this process. Scientists often call this combination of inflammation and ageing 'inflammageing'. Over time, it can put extra strain on your heart and blood vessels, causing cells to age faster than they usually would.
Metformin is a well-known, safe medicine that doctors have prescribed for decades to help lower blood sugar in type 2 diabetes. However, doctors have noticed that metformin seems to do more than just control sugar. Early research suggests it might also act as a shield for our cells, cooling down inflammation and helping blood vessels stay healthier and younger for longer.
In this study, researchers want to see exactly how metformin affects these hidden biological processes in people who have pre-diabetes. By examining specific markers in the blood, the team hopes to find out whether starting metformin early can stop or slow down the cellular wear-and-tear linked to ageing and cardiovascular problems.
Wichtige Erkenntnisse
- The study tests whether the diabetes drug metformin can reduce inflammation and slow down cell ageing.
- It is open to adults aged 18 and over who have pre-diabetes.
- Participants take a metformin tablet daily for 18 months.
- You will attend check-ups with blood tests at the start, 6 months, 12 months, and 18 months.
- Participation is entirely voluntary, and you can withdraw at any time.
Wer könnte berechtigt sein?
This study is open to adults aged 18 and over who have been diagnosed with pre-diabetes. Both men and women can take part. Pre-diabetes means your blood sugar levels are raised above the normal range, but not quite high enough to be diagnosed as type 2 diabetes.
Because this study uses metformin, you may not be able to join if you have certain existing medical conditions, such as severe kidney or liver problems, or if you are already taking medications that could clash with the study treatment.
A study doctor will look through your medical history and test your blood to make sure it is completely safe for you to take metformin before you agree to join.
Könnte diese Studie für Sie geeignet sein?
Beantworten Sie diese kurzen Fragen, um zu sehen, ob Sie möglicherweise berechtigt sind. Dies ist nur ein Leitfaden – das Forschungsteam trifft die endgültige Entscheidung.
- I am aged 18 or older.
- I have been told by a doctor that I have pre-diabetes or borderline blood sugar.
- I am able and willing to take a daily tablet for 18 months.
- I can attend regular clinic visits for blood tests over an 18-month period.
- I do not have severe kidney or liver problems that prevent me from taking metformin.
Was beinhaltet die Teilnahme?
Taking part in the study lasts for about 18 months in total. During this time, you will take a daily tablet of metformin (Dianben 850 mg) as advised by the study team.
You will be asked to attend clinic appointments at the start of the study, and then at 6, 12, and 18 months. During these visits, the medical team will measure your weight, height (to calculate your body mass index), and blood pressure. You will also give routine blood samples so the researchers can track your blood sugar levels (HbA1c), cholesterol, and specific markers of inflammation and cell ageing.
Between visits, you will continue with your normal daily life and keep the study team updated on how you are feeling or if you notice any changes in your health.
Potenzielle Risiken und Vorteile
Standorte (1)
- —UnbestätigtSpanien
Häufige Fragen
Was ist Prädiabetes?
Pre-diabetes means your blood sugar levels are higher than usual, but not yet high enough to be called type 2 diabetes. It is a warning sign that gives you a chance to take action to protect your future health.
Is metformin a new or experimental drug?
No. Metformin has been safely prescribed to millions of people worldwide for many decades. This trial is exploring new ways it might help the body beyond its standard role in managing blood sugar.
Will taking part hurt?
The study involves standard blood tests at your visits, which can cause a brief scratch or mild bruising, similar to any routine blood test at your GP surgery.
Kann ich die Studie verlassen, wenn ich meine Meinung ändere?
Yes. You have the right to withdraw from the trial at any time, for any reason, and your regular medical care will not be affected in any way.
Do I have to pay to take part?
No, clinical trials do not charge you to take part. All study-related medicines and tests are provided free of charge, and some trials may help with travel expenses.
Wie Sie mehr erfahren können
Sprechen Sie immer mit Ihrem Hausarzt oder Spezialisten, bevor Sie sich entscheiden, an einer Studie teilzunehmen.
Diskussion
Community-Diskussion
Bereitgestellt von unserem Forum bei community.patient.info. Bitte seien Sie respektvoll — dies ist kein medizinischer Rat.